Madorra this week said it has received FDA breakthrough device designation for its noninvasive, home-use device for moderate to severe vulvovaginal atrophy. Through the breakthrough device program, Madorra will have priority review and communication regarding the development of the device until the product goes on the market. Madorra’s handheld device is designed as a prescription, … Continue reading Madorra wins FDA breakthrough nod for home vulvovaginal atrophy treatment device